VR Project for Treating Vision Disorders Secures $2.2m Funding

Estimates say that 10% of the American population suffer from some form of binocular vision disorder, such as lazy eyes. These disorders can cause problems with driving, playing sports and prevent sufferers from viewing 3D content. Vivid Vision is a new company that is aiming to treat those disorders with an innovative use of virtual reality (VR) technology.

Vivid Vision founder and CEO James Blaha was himself a sufferer of lazy eye, which made him unable to read with his weak eye, or see 3D content properly, but he discovered a method to treat his lazy eye problem using a modified Oculus Rift. Since starting his experimental treatment with the Oculus Rift his vision has improved until it is almost 20/20.

The company is planning to use the new investments from SoftTech VC, The VR Fund, CRCM Ventures, SOS Ventures and others to expand and accelerate the vision care platform. Treatment from Vivid Vision’s product is currently available in over 90 clinics all over the world and has treated more than 6,000 patients. Vivid Vision is also seeking to produce a home version which the company hopes to have available later in the year.

“It is a unique, far more efficient solution to treat Amblyopia as well as a wide array of binocular vision dysfunction,” said, Dr. Dan Fortenbacher, founder of Wow Vision Therapy, which has two locations in Michigan and was one of the first practices to begin using VR as part of treatment. “The progress the patient makes in breaking through suppression and developing 3D vision has been remarkable with Vivid Vision.”

“Vivid Vision Home will make vision therapy accessible to millions of new patients for whom treatment was previously too expensive or inconvenient,” adds CEO James Blaha. “We’re really fortunate to be partnered with the best optometrists, ophthalmologists, and vision scientists to make this a reality.”

VRFocus will bring you further news on Vivid Vision and other VR health products as it becomes available.